1. Search Result
Search Result
Results for "

GW-572016

" in MedChemExpress (MCE) Product Catalog:

9

Inhibitors & Agonists

4

Isotope-Labeled Compounds

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-50898
    Lapatinib
    Maximum Cited Publications
    63 Publications Verification

    GW572016; GW2016

    EGFR Autophagy Ferroptosis Cancer
    Lapatinib (GW572016) is a potent inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
    Lapatinib
  • HY-50898B
    Lapatinib ditosylate monohydrate
    Maximum Cited Publications
    63 Publications Verification

    GW572016 ditosylate monohydrate; GW2016 ditosylate monohydrate

    EGFR Autophagy Ferroptosis Cancer
    Lapatinib ditosylate monohydrate (GW572016 ditosylate monohydrate) is a potent inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
    Lapatinib ditosylate monohydrate
  • HY-50898A
    Lapatinib ditosylate
    Maximum Cited Publications
    63 Publications Verification

    GW572016 ditosylate; GW2016 ditosylate

    EGFR Autophagy Ferroptosis Cancer
    Lapatinib ditosylate (GW572016 ditosylate) is a potent inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
    Lapatinib ditosylate
  • HY-50898C

    GW572016 tosylate; GW2016 tosylate

    EGFR Ferroptosis Autophagy Cancer
    Lapatinib (GW572016) tosylate is a potent, orally active inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
    Lapatinib tosylate
  • HY-50898S1

    GW572016-dd7 dihydrochloride; GW2016-dd7 dihydrochloride

    Isotope-Labeled Compounds EGFR Autophagy Ferroptosis Cancer
    Lapatinib-d7 (dihydrochloride) is the deuterium labeled Lapatinib dihydrochloride. Lapatinib (GW572016) dihydrochloride is a potent inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively[1].
    Lapatinib-d7 dihydrochloride
  • HY-50898S2

    GW572016-d5; GW2016-d5

    Isotope-Labeled Compounds EGFR Autophagy Ferroptosis Cancer
    Lapatinib-d5 is deuterium labeled Lapatinib. Lapatinib (GW572016) is a potent inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively[1].
    Lapatinib-d5
  • HY-50898S3

    GW572016-d4-1; GW2016-d4-1

    Isotope-Labeled Compounds EGFR Autophagy Ferroptosis Cancer
    Lapatinib-d4-1 is deuterium labeled Lapatinib. Lapatinib (GW572016) is a potent inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively[1].
    Lapatinib-d4-1
  • HY-50898S

    GW572016-d4; GW2016-d4

    EGFR Autophagy Ferroptosis Cancer
    Lapatinib-d4 is the deuterium labeled Lapatinib (HY-50898). Lapatinib is a potent inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively[1][2].
    Lapatinib-d4
  • HY-50898R

    Cancer
    Lapatinib (Standard) is the analytical standard of Lapatinib. This product is intended for research and analytical applications. Lapatinib (GW572016) is a potent inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
    Lapatinib (Standard)

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: